1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients
Autor: | Francolini, G., Detti, B., Di Cataldo, V., Caini, S., Alitto, A.R., S. Parisi, Demofonti, C., Bruni, A., Ingrosso, G., Timon, G., Allegra, A.G., Burchini, L., Salvestrini, V., Frosini, G., Cerbai, C., Visani, L., Becherini, C., Desideri, I., Meattini, I., Livi, L. |
---|---|
Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1167-S1168 |
Databáze: | ScienceDirect |
Externí odkaz: |